Related Experiment Video
Updated: Jan 3, 2026

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
Icariin reduces high glucose-induced endothelial progenitor cell dysfunction via inhibiting the p38/CREB pathway and
Sisi Chen1,2,3, Zhenya Wang1,2,3, Heng Zhou1,2,3
1Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan, Hubei 430060, P.R. China.
Insights
Icariin improves high glucose-induced endothelial progenitor cell (EPC) dysfunction by inhibiting the p38/CREB pathway and activating the Akt/eNOS/NO pathway. This natural compound shows potential for treating conditions involving impaired EPC function.
Area of Science:
- Cardiovascular Biology
- Cellular and Molecular Medicine
- Pharmacology and Therapeutics
Background:
- High glucose (HG) negatively impacts endothelial progenitor cell (EPC) function, a critical process in vascular health.
- The p38 mitogen-activated protein kinase pathway activation and Akt/endothelial nitric oxide (NO) synthase (eNOS)/NO pathway inhibition are key mechanisms in HG-induced EPC dysfunction.
- Icariin, a natural compound, has demonstrated protective effects on endothelial cells.
Purpose of the Study:
- To investigate the therapeutic effects of icariin on high glucose-induced dysfunction in EPCs.
- To assess icariin's impact on EPC proliferation, migration, and tube formation.
- To elucidate the molecular mechanisms underlying icariin's protective actions on EPCs.
Main Methods:
- Endothelial progenitor cells (EPCs) were isolated from Sprague-Dawley rats and treated with high glucose in vitro.
- The effects of varying icariin concentrations on EPC proliferation, migration, and tube formation were evaluated.
- Western blotting was used to analyze the phosphorylation status of p38, cAMP response element binding protein (CREB), Akt, and eNOS.
- Nitric oxide (NO) production was measured to assess pathway activation.
Main Results:
- Icariin dose-dependently reversed HG-induced inhibition of EPC proliferation, with maximal efficacy at 1 µM.
- A concentration of 1 µM icariin partially restored HG-impaired EPC migration and tube formation.
- Icariin significantly suppressed HG-induced p38 and CREB phosphorylation while increasing Akt and eNOS activation.
- Icariin treatment led to increased NO production in EPCs.
Conclusions:
- Icariin effectively attenuates high glucose-induced endothelial progenitor cell dysfunction.
- The protective effects of icariin are partly mediated by inhibiting the p38/CREB pathway.
- Icariin promotes EPC function through the activation of the Akt/eNOS/NO pathway.
- Icariin presents a potential therapeutic candidate for conditions characterized by impaired EPC function.
Abstract:
High glucose (HG) impairs endothelial progenitor cell (EPC) function. The activation of p38 mitogen-activated protein kinase and the inhibition of the Akt/eNOS/NO pathway serve central roles in this process. Icariin has protective effects in endothelial cells. The aim of the present study was to investigate the effects of icariin on HG-induced EPC dysfunction, including proliferation, migration and tube formation. Experiments were performed with EPCs isolated from the femurs and tibias of Sprague-Dawley rats in vitro. In a dose-dependent manner, icariin reversed the inhibition of EPC proliferation induced by HG treatment, and the maximal effective concentration of icariin was 1 µM [Fold change (FC):0.90±0.07, P=0.0124 vs. HG group]. The impaired EPC migration and tube formation induced by glucose was partially restored by 1 µM icariin treatment (FC: 0.81±0.08, P=0.0148 vs. HG group for migration; 0.82±0.03, P=0.0214 vs. HG group for tube formation). Furthermore, icariin significantly suppressed HG-induced p38 and cAMP response element binding protein (CREB) phosphorylation in EPCs (FC: 1.84±0.21, P=0.0238 vs. HG group for p38; FC: 2.24±0.15, P=0.0068 vs. HG group for CREB). Increased Akt and endothelial nitric oxide (NO) synthase (eNOS) activation was also observed after icariin treatment (FC: 0.64±0.08, P=0.0047 vs. HG group for Akt; FC:0.53±0.05, P=0.0019 vs. HG group for eNOS), which was followed by increased NO production (FC: 0.69±0.06, P=0.0064 vs. HG group). In conclusion, icariin attenuated HG-induced EPC dysfunction, which may be partially attributed to the inhibition of the p38/CREB pathway and the activation of the Akt/eNOS/NO pathway. Icariin may be a therapeutic candidate for improving the function of EPC.
More Related Videos
Related Concept Videos
cAMP-dependent Protein Kinase Pathways
Cell Specific Gene Expression
Dipeptidyl Peptidase 4 Inhibitors
GPCRs Regulate Adenylyl Cylase Activity
PI3K/mTOR/AKT Signaling Pathway
Inhibition of Cdk Activity

